← Leaderboards
John Douglas Hulleman
Ut Southwestern Medical Center
$4,556,444
Attributed
$4,556,444
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $916.7K · FY2017–24$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,556,444 · 5
By mechanism
R01$2,303,954 · 1
R21$1,336,250 · 3
P30$916,240 · 1
Top collaborators
No co-investigators on record.
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Shusheng Wang$6,641,450
- Rafael Ufret-Vincenty$4,610,296
- Marcel Bernard Mettlen$2,152,886
Others in their field
Other Emerging Leaders on “Proteins”
- John Damon Chodera · Sloan-Kettering Inst Can Research$50,971,767
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Timothy Fouts · Advanced Bioscience Laboratories, Inc.$40,723,314
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
Research focus
ProteinsIn VivoCellsAffectIn VitroPhenotypeRetinaProductionVisionGenerationsResearch PersonnelSignal TransductionFutureGenetic EngineeringKnock-DownPreventBiologyCell Culture TechniquesMutationAge Related Macular DegenerationGeneticDoseInsightEarly Onset
Grant awards (21)
Functional Ocular Chemoproteomics for Retinal Biology Insight and in vivo Enzyme Activity$193,750
R21 · FY2024 · EY · contact PI
Functional Ocular Chemoproteomics for Retinal Biology Insight and in vivo Enzyme Activity$233,600
R21 · FY2023 · EY · contact PI
Molecular Biology/Virus Production$188,560
P30 · FY2023 · EY · contact PI
Development and application of chemical timers for precise control of protein abundance in the eye (R21 3522)$126,941
R21 · FY2023 · EY · contact PI
Development and application of chemical timers for precise control of protein abundance in the eye$78,059
R21 · FY2023 · EY · contact PI
Functional Ocular Chemoproteomics for Retinal Biology Insight and in vivo Enzyme Activity$12,400
R21 · FY2023 · EY · contact PI
Prevention of macular pathophysiology associated with F3 misfolding$405,933
R01 · FY2022 · EY · contact PI
Development and application of chemical timers for precise control of protein abundance in the eye$246,000
R21 · FY2022 · EY · contact PI
Molecular Biology/Virus Production$188,560
P30 · FY2022 · EY · contact PI
Prevention of macular pathophysiology associated with F3 misfolding (RO1 transfer)$76,162
R01 · FY2022 · EY · contact PI
Prevention of macular pathophysiology associated with F3 misfolding$462,540
R01 · FY2021 · EY · contact PI
Molecular Biology/Virus Production$188,560
P30 · FY2021 · EY · contact PI
Prevention of macular pathophysiology associated with F3 misfolding - Admin Suppl$100,432
R01 · FY2021 · EY · contact PI
Prevention of macular pathophysiology associated with F3 misfolding$405,000
R01 · FY2020 · EY · contact PI
Molecular Biology/Virus Production$188,560
P30 · FY2020 · EY · contact PI
Supplement to Promote Diversity in Health-Related Research - Prevention of macular pathophysiology...Parent Grant$43,887
R01 · FY2020 · EY · contact PI
Prevention of macular pathophysiology associated with F3 misfolding$405,000
R01 · FY2019 · EY · contact PI
Molecular Biology/Virus Production$162,000
P30 · FY2019 · EY · contact PI
Prevention of macular pathophysiology associated with F3 misfolding$405,000
R01 · FY2018 · EY · contact PI
A broadly applicable, regulatable strategy to control signaling in the retina.$202,500
R21 · FY2018 · EY · contact PI
A broadly applicable, regulatable strategy to control signaling in the retina.$243,000
R21 · FY2017 · EY · contact PI